Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 1, 2002, Pages 6-13

  Brenner, David J ^a   Martinez, Alvaro A ^b   Edmundson, Gregory K ^b   Mitchell, Christina ^b   Thames, Howard D ^c   Armour, Elwood P ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

HDR; Hypofractionation; Prostate cancer; Radiotherapy

Indexed keywords

DRUG DOSAGE; FRACTIONATION; PATIENT TREATMENT; POISSON DISTRIBUTION; RADIOTHERAPY; SENSITIVITY ANALYSIS; TISSUE; TUMORS;

BRACHYTHERAPY;

DISEASES;

IRIDIUM 192; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER CONTROL; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE TUMOR; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOISOTOPE THERAPY; RADIOSENSITIVITY; RADIOTHERAPY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

AGED; BRACHYTHERAPY; DOSE FRACTIONATION; FOLLOW-UP STUDIES; HUMANS; IRIDIUM RADIOISOTOPES; MALE; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY, CONFORMAL; TREATMENT FAILURE;

EID: 0036140325     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02664-5     Document Type: Article

References (36)

1. Fractionation and protraction for radiotherapy of prostate carcinoma
2. What is the α/β ratio for prostate cancer? Rationale for hypofractionated high-dose rate brachytherapy
3. Is alpha/beta for prostate tumors really low?
4. Toward optimal external-beam fractionation for prostate cancer
5. A simple analytic derivation suggests that prostate cancer α/β ratio is low
6. Is the α/β ratio for prostate cancer low?
7. Cell kinetic measurements in prostate cancer
8. Changes in early and late radiation responses with altered dose fractionation; Implications for dose-survival relationships
9. 192Ir brachytherapy sources
10. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer; The William Beaumont phase II dose-escalating trial
11. Consensus statement; Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel
12. The definition of biochemical failure in patients treated with definitive radiotherapy
13. Prostate specific antigen density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy
14. An enhanced prognostic system for clinically localized carcinoma of the prostate
15. Prognostic factors for clinically localized prostate carcinoma; Analysis of 938 patients irradiated in the prostate specific antigen era
16. Predicting tumor failure in prostate carcinoma after definitive radiation therapy; Limitations of models based on prostate-specific antigen, clinical stage, and Gleason score
17. How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics?
18. The mechanism of the induction by radiation of chromosome aberrations in Tradescantia
19. The Linear-Quadratic model and most other common radiobiological models result in similar predictions for time-dose relationships
20. Nonparametric estimation from incomplete observations
21. Evaluation of survival data and two new rank order statistics arising in its consideration
22. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can reasonably supposed to have arisen from random sampling
23. Time-dose factors in radiotherapy; A review of the human data
24. The linear-quadratic formula and progress in fractionated radiotherapy
25. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era
26. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
27. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer; Treatment description and preliminary results of a phase I/II clinical trial
28. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer; A feasibility report
29. Radical treatment of prostatic carcinoma by megavoltage X-ray therapy
30. External radiation therapy for prostatic carcinoma
31. Retrospective study of radiotherapy in early carcinoma of the prostate
32. Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation; Twenty-two years' experience (1962-1984)
33. Hypofractionation for prostate cancer
34. Carcinoma of the prostate; Results of radical radiotherapy (1970-1985)